If youre pregnant, planning to become pregnant, or breastfeeding, talk to your doctor about alternative weight management options
Three: the founder personal-brand exposure is real
The EMPA-REG OUTCOMES trial showed that empagliflozin, a SGLT-2i, markedly reduced the risk for HF hospitalization relative to the placebo ( HR = 0.65, 95% CI 0.500.85, P = 0.002) [96]
This suggests Novo may have dedicated specific pill-production lines (tableting, coating and packaging) at an existing site, along with an API bulk synthesis line built or repurposed there
However, the optimal wearing time would be determined by the specific product design, drug formulation, and delivery technology, and would be clearly specified in any future product's Patient Information Leaflet (PIL) if approved
It can help reduce the risk of heart disease, stroke, and other complications linked to diabetes